Sentinelle Medical, Siemens Healthcare to jointly develop solutions for Interventional Prostate MRI

NewsGuard 100/100 Score

Sentinelle Medical Inc., a leading manufacturer of breast MRI coils and software, and Siemens Healthcare today announced at the Radiological Society of North America (RSNA) annual meeting in Chicago, that they are collaborating on the development of a suite of innovative solutions for Interventional Prostate MRI.

According to the American Cancer Society, Prostate cancer will affect close to 200,000 men and cause 27,000 deaths this year (2009) in the US. Current screening technologies are limited in their ability to reliably detect prostate cancer. Prostate MRI shows significant promise to address these challenges. However, initial offerings offer limited signal-to-noise ratios (SNR) coverage for the prostate, and current interventional solutions lack the ability to combine with internal imaging coils.

Sentinelle and Siemens are working together to develop solutions that will address the challenges clinicians currently face in the use of MRI for imaging, intervention and treatment of prostate cancer. These solutions will address image quality, ease and accuracy of intervention, patient experience and workflow efficiency - all critical elements in the widespread adoption of prostate MRI. Sentinelle will be demonstrating Works-In-Progress for Prostate interventional MRI coils at RSNA 2009 (Booth 5800, Hall A).

"Prostate imaging provides unique challenges for imaging and intervention. Siemens and Sentinelle are dedicated to delivering solutions that can be easily integrated into the clinicians workflow, and positively impact patient outcomes," said Cameron Piron, Sentinelle's President and CEO. "With our combined focus, we are confident that we can address these challenges and enable greater access to this important technology."

"MRI plays an important role in detecting prostate cancer. Our focus is to further develop innovative technologies that help improve patient care and healthcare efficiency," says Dr. Robert Krieg, Vice President Product Definition, Magnetic Resonance, Siemens Healthcare.

Source:

SENTINELLE MEDICAL INC., SIEMENS AG

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New cancer projections show increased prostate cases by 25% in 2050, despite prevention efforts